PL3010496T3 - Arginina do zastosowania w leczeniu i/lub zapobieganiu chorobie zwyrodnieniowej stawów - Google Patents

Arginina do zastosowania w leczeniu i/lub zapobieganiu chorobie zwyrodnieniowej stawów

Info

Publication number
PL3010496T3
PL3010496T3 PL14741388T PL14741388T PL3010496T3 PL 3010496 T3 PL3010496 T3 PL 3010496T3 PL 14741388 T PL14741388 T PL 14741388T PL 14741388 T PL14741388 T PL 14741388T PL 3010496 T3 PL3010496 T3 PL 3010496T3
Authority
PL
Poland
Prior art keywords
osteoarthritis
arginine
prevention
treatment
Prior art date
Application number
PL14741388T
Other languages
English (en)
Inventor
Giuseppe Colombo
Walter Pascale
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of PL3010496T3 publication Critical patent/PL3010496T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL14741388T 2013-06-20 2014-06-19 Arginina do zastosowania w leczeniu i/lub zapobieganiu chorobie zwyrodnieniowej stawów PL3010496T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001028A ITMI20131028A1 (it) 2013-06-20 2013-06-20 Arginina e/o citrullina per uso nel trattamento e/o nella prevenzione dell'artrosi
PCT/IB2014/062450 WO2014203200A1 (en) 2013-06-20 2014-06-19 Arginine and/or citrulline for use in the treatment and/or prevention of osteoarthritis
EP14741388.4A EP3010496B1 (en) 2013-06-20 2014-06-19 Arginine for use in the treatment and/or prevention of osteoarthritis

Publications (1)

Publication Number Publication Date
PL3010496T3 true PL3010496T3 (pl) 2020-03-31

Family

ID=49035714

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14741388T PL3010496T3 (pl) 2013-06-20 2014-06-19 Arginina do zastosowania w leczeniu i/lub zapobieganiu chorobie zwyrodnieniowej stawów

Country Status (14)

Country Link
EP (1) EP3010496B1 (pl)
CY (1) CY1122377T1 (pl)
DK (1) DK3010496T3 (pl)
EA (1) EA030755B1 (pl)
ES (1) ES2764177T3 (pl)
HR (1) HRP20192028T1 (pl)
HU (1) HUE047636T2 (pl)
IT (1) ITMI20131028A1 (pl)
LT (1) LT3010496T (pl)
PL (1) PL3010496T3 (pl)
PT (1) PT3010496T (pl)
RS (1) RS59723B1 (pl)
SI (1) SI3010496T1 (pl)
WO (1) WO2014203200A1 (pl)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346519B1 (en) * 1998-09-09 2002-02-12 Advanced Medical Instruments Method and composition for treating arthritis
DE10246340A1 (de) * 2002-10-04 2004-04-29 Wohlrab, David, Dr. Kombinationspräparat aus Hyaluronsäure und mindestens einem Lokalanästhetikum und dessen Verwendung
US20080287349A1 (en) * 2003-05-09 2008-11-20 Jeffrey Peterson Fibroblast growth factor 20 and methods of use thereof
US20050119275A1 (en) * 2003-06-24 2005-06-02 Pfizer Inc. Salt and crystal forms of (5-chloro-2-{2-[4-(4-fluoro-benzyl)-(2R,5S)-2,5-dimethyl-piperazin-1-yl]-2-oxo-ethoxy}-phenyl)-methanesulfonic acid
ZA200710598B (en) * 2005-06-17 2009-08-26 Dynamis Therapeutics Inc Treatment of inflammatory conditions
CN101780181A (zh) * 2009-01-16 2010-07-21 陈祥槐 一氧化氮自由基保健品
ES2356762B1 (es) * 2009-09-04 2011-11-24 Farmalider S.A. Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma.

Also Published As

Publication number Publication date
EA201690070A1 (ru) 2016-05-31
ITMI20131028A1 (it) 2014-12-21
RS59723B1 (sr) 2020-01-31
HRP20192028T1 (hr) 2020-02-07
EP3010496B1 (en) 2019-10-02
LT3010496T (lt) 2020-01-10
CY1122377T1 (el) 2021-01-27
DK3010496T3 (da) 2019-11-25
ES2764177T3 (es) 2020-06-02
HUE047636T2 (hu) 2020-05-28
PT3010496T (pt) 2019-12-09
WO2014203200A1 (en) 2014-12-24
EA030755B1 (ru) 2018-09-28
EP3010496A1 (en) 2016-04-27
SI3010496T1 (sl) 2019-12-31

Similar Documents

Publication Publication Date Title
HK1216251A1 (zh) 吡唑並吡咯烷衍生物及其治病作用
ZA201604810B (en) Surface treatment of particles and their use
ZA201604860B (en) Surface treatment of particles and their use
IL242483B (en) Preparations containing omomyc and their use for cancer treatment
PT3004108T (pt) Derivados de pirazolo-pirrolidin-4-ona como inibidores de bet e a sua utilização no tratamento de doenças
PL3004112T3 (pl) Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby
HUE052930T2 (hu) DNQ vagy DNQ-87 alkalmazása PARP1-inhibitorral kombinációban rák kezelésére
HK1220374A1 (zh) 用於治療碳氧血紅蛋白血症的組合物和方法
PL2862576T3 (pl) Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka
HK1209033A1 (zh) 奧地帕西在治療黏多醣症病中的應用
PL3010496T3 (pl) Arginina do zastosowania w leczeniu i/lub zapobieganiu chorobie zwyrodnieniowej stawów
PL3041459T3 (pl) Kompozycje przydatne w zapobieganiu lub leczeniu raka skóry
PL3082798T3 (pl) Pochodne benzodioksolu do stosowania w leczeniu deficytu uwagi i nadpobudliwości
AP2015008849A0 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease